TL;DR
Turn your wind-down time into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
A paper in The Lancet Healthy Longevity argues that sarcopenia and age-related mobility loss should be understood as problems involving the wider motor system, including the brain, nerves and muscles. The authors propose changes to research and clinical assessment, but say it has not been shown that their suggested measures improve outcomes or reduce costs.
Researchers writing in The Lancet Healthy Longevity argue that age-related weakness and mobility loss should be understood as changes across the motor system, not simply as declining muscle. Their proposal could alter how clinicians assess sarcopenia, but the authors say new measures still need testing before their value in routine care is known.
The paper, by Lucas B. R. Orssatto and colleagues, says muscle loss accounts for only a modest share of the decline in strength seen with age. People with similar amounts of muscle can have different levels of strength and mobility, the authors write, while exercise can improve function even when measurable muscle mass does not change.
The proposed explanation includes the brain, spinal cord, nerves and their connections to muscle. Age-related changes across that system may affect how movements are planned, how reliably signals reach muscles, and how well a person senses position and maintains balance. The authors point to standing from a chair as a task that depends on speed and power as well as muscle size.
Current diagnostic approaches already give more weight to function than muscle mass: measures such as grip strength, walking speed and chair stands are used because they predict outcomes including falls and disability more effectively than mass alone. The paper argues that the explanation of sarcopenia should catch up with this functional emphasis.
The proposal matters because it shifts attention from whether an older person has lost muscle to how well the body can produce and coordinate movement. If that model is borne out, assessment and treatment research may need to address nerve function, balance, coordination and muscle together rather than treating muscle growth as the main goal.
The issue has practical importance for older adults at risk of falls and loss of independence. Medical Xpress reports that sarcopenia affects up to 29% of community-dwelling older adults, with higher rates in hospital and residential-care settings and among people with frailty or multiple health conditions. The article also reports 253,800 fall-related hospitalizations in Australia in 2024–25 and 6,722 deaths following falls in 2023–24. These figures describe the scale of fall-related harm; they do not show that the proposed motor-system approach would prevent those events.
The authors say a broader model could guide more targeted care and direct investment toward interventions that improve everyday function. That remains a potential consequence, not a demonstrated clinical benefit.
Popular right now
Roborock Robot Vacuum and Mop with LiDAR Navigation and 10,000 Pa Suction
Roborock RockNeo Q110H Wire-Free Robot Lawn Mower
Breville Bambino Espresso Machine, Brushed Stainless Steel
As an affiliate, we earn on qualifying purchases.
How Sarcopenia Assessment Has Shifted
Sarcopenia is commonly described as a substantial loss of muscle, strength and physical function associated with aging. It is linked to frailty, disability and reduced independence, while falls are among its clearest risks. The Medical Xpress report notes that falls are the leading cause of injury-related hospitalization and death in Australia.
Earlier in 2026, the Australian Journal of General Practice published a proposed algorithm to help primary-care teams screen for, assess and manage poor muscle health. The new paper builds on that clinical attention but questions whether the underlying account remains too focused on muscle. It calls on international groups responsible for diagnostic criteria to consider a five-point research and practice agenda.
For primary care, the authors suggest retaining strength and walking-speed checks while also paying attention to how quickly a person rises from a chair, steadiness during sustained effort, hand dexterity and walking while talking. They also recommend closer examination when weakness is asymmetric, develops rapidly or seems out of proportion to muscle loss. These are proposals from the authors, not a validated replacement for current screening.
“We propose that sarcopenia is better understood as a disease of the aging motor system.”
— Orssatto and colleagues, in The Lancet Healthy Longevity
Clinical Value Still Needs Testing
The paper presents a framework and research agenda, not evidence that a motor-system diagnosis or the proposed checks improve patient outcomes. The authors explicitly say the suggested measures have not been shown to outperform existing screening on outcomes or cost. It is also unclear which practical tests would be reliable and feasible for primary-care teams, where access to neuromuscular expertise varies.
The source material does not report a clinical trial testing a treatment based on this model, nor does it establish how much of an individual patient’s weakness comes from muscle, nerves, the central nervous system or other causes. The proposal should not be read as a claim that muscle loss is irrelevant; rather, the authors argue it is an incomplete explanation.
Testing Measures and Updating Guidance
The authors call for research to validate practical tests, develop guidance for a staged assessment and run trials that measure changes in both nerve and muscle function. They also urge diagnostic working groups to consider whether criteria should better reflect the wider motor system.
For now, the report describes a proposed change in scientific framing, not an announced change to clinical guidelines. Any shift in routine practice will depend on whether follow-up studies show that the additional assessments are useful, workable and linked to better outcomes for older adults.
Key Questions
What is sarcopenia?
Sarcopenia refers to substantial loss of muscle, strength and physical function associated with aging. The paper argues that muscle loss alone does not explain the full decline in strength and mobility.
What does the motor-system proposal include?
It includes the brain, spinal cord, nerves and their connections to muscle, as well as muscle itself. The authors say changes across this system may affect movement, strength, balance and coordination.
Does the paper show that new tests prevent falls?
No. The paper proposes additional assessment measures, but the authors say they have not been shown to outperform existing screens on health outcomes or cost.
What checks do the authors suggest considering?
Alongside strength and walking speed, they suggest observing chair-rise speed, steadiness during sustained effort, hand dexterity and walking while talking. These suggestions need further validation and are not established replacements for current assessments.
What happens before this proposal changes clinical care?
Researchers need to test practical measures and treatments, including trials that assess nerve as well as muscle. Clinical guidance may change if evidence shows the broader approach is feasible and improves outcomes.
Source: medicalxpress.com
